We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lonza Announces Suites for Commercialization of Bioconjugates

Product News   Dec 03, 2020

 
Lonza Announces Suites for Commercialization of Bioconjugates
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Optibrium Enhances Compound Design Strategies

Product News

Optibrium™ today announced the release of the newest version of StarDrop™, a comprehensive software platform for small molecule design, optimisation and data analysis.

READ MORE

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

Product News

Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression.

READ MORE

CN Bio’s PhysioMimix Technology Receives FDA Recognition

Product News

FDA publication demonstrates the advantages of PhysioMimix in drug safety and metabolism applications, over standard techniques.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE